Nigel T Brockton

Dr. Nigel T Brockton

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
MSMarissa M Shams-White
Marissa M Shams-White
NBNigel T Brockton
Nigel T Brockton
PMPanagiota Mitrou
Panagiota Mitrou
DRDora Romaguera
Dora Romaguera
SBSusannah Brown
Susannah Brown
JRJill Reedy
Jill Reedy
Background: Following the publication of the 2018 World Cancer Research Fund (WCRF) and American Institute for Cancer Research (AICR) Third Expert Report, a collaborative group was formed to develop a standardized scoring system and provide guidance for research applications. Methods: The 2018 WCRF/AICR Cancer Prevention Recommendations, goals, and statements of advice were examined to define components of the new Score. Cut-points for scoring were based on quantitative guidance in the 2018 Recommendations and other guidelines, past research that operationalized 2007 WCRF/AICR Recommendations, and advice from the Continuous Update Project Expert Panel. Results: Eight of the ten 2018 WCRF/AICR Recommendations concerning weight, physical activity, diet, and breastfeeding (optional), were selected for inclusion. Each component is worth one point: 1, 0.5, and 0 points for fully, partially, and not meeting each recommendation, respectively (Score: 0 to 7–8 points). Two recommendations on dietary supplement use and for cancer survivors are not included due to operational redundancy. Additional guidance stresses the importance of accounting for other risk factors (e.g., smoking) in relevant models. Conclusions: The proposed 2018 WCRF/AICR Score is a practical tool for researchers to examine how adherence to the 2018 WCRF/AICR Recommendations relates to cancer risk and mortality in various adult populations.

7 December 2022 in JNCI Cancer Spectrum
Verified
Journal Article
Open access
PDF file
DADagfinn Aune
Dagfinn Aune
GMGeorgios Markozannes
Georgios Markozannes
LALeila Abar
Leila Abar
KBKatia Balducci
Katia Balducci
MCMargarita Cariolou
Margarita Cariolou
DCDoris S M Chan
Doris S M Chan
Physical activity (PA) is associated with improved health-related quality of life (HRQoL) among women with breast cancer; however, uncertainty remains regarding PA types and dose (frequency, duration, intensity) and various HRQoL measures. A systematic review and meta-analysis of randomized controlled trials was conducted to clarify whether specific types and doses of physical activity was related to global and specific domains of HRQoL, as part of the Global Cancer Update Programme, formerly known as the World Cancer Research Fund–American Institute for Cancer Research Continuous Update Project. PubMed and CENTRAL databases were searched up to August 31, 2019. Weighted mean differences (WMDs) in HRQoL scores were estimated using random effects models. An independent expert panel graded the evidence. A total of 79 randomized controlled trials (14 554 breast cancer patients) were included. PA interventions resulted in higher global HRQoL as measured by the Functional Assessment of Cancer Therapy–Breast (WMD = 5.94, 95% confidence intervals [CI] = 2.64 to 9.24; I2 = 59%, n = 12), Functional Assessment of Cancer Therapy–General (WMD = 4.53, 95% CI = 1.94 to 7.13; I2 = 72%, n = 18), and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire–C30 (WMD = 6.78, 95% CI = 2.61 to 10.95; I2 = 76.3%, n = 17). The likelihood of causality was considered probable that PA improves HRQoL in breast cancer survivors. Effects were weaker for physical function and mental and emotional health. Evidence regarding dose and type of PA remains insufficient for firm conclusions. PA results in improved global HRQoL in breast cancer survivors with weaker effects observed for physical function and mental and emotional health. Additional research is needed to define the impact of types and doses of activity on various domains of HRQoL.

25 July 2022 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Closed access
PDF file
AKAriella R. Korn
Ariella R. Korn
JRJill Reedy
Jill Reedy
NBNigel T Brockton
Nigel T Brockton
LKLisa L. Kahle
Lisa L. Kahle
PMPanagiota Mitrou
Panagiota Mitrou
MSMarissa M Shams-White
Marissa M Shams-White
Background: We examined associations between adherence to the 2018 World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Cancer Prevention Recommendations using the standardized 2018 WCRF/AICR Score and cancer risk among older U.S. adults. Methods: Participants included 215,102 adults in the NIH-AARP Diet and Health Study followed between 2004 and 2011 (mean 7.0 person-years). Scores (range: 0–7 points) were calculated from self-reported weight, physical activity, and diet and alcohol intake measures. Outcomes included 17 cancers reviewed by WCRF/AICR (cases: male n = 11,066; female n = 8,865) and top three U.S. cancers in males (total n = 4,658; lung n = 2,211; prostate n = 920; colorectal n = 1,527) and females (total n = 5,957; lung n = 1,475; post-menopausal breast n = 3,546; colorectal n = 936). Cox proportional hazard ratios (HRs) were estimated for score and cancer risk associations, stratifying by sex and smoking status. Results: Each one-point score increase was associated with 6% to 13% reduced cancer risk across combined outcomes, except for male never smokers’ risk for top three cancers and male current smokers’ risk for both combined cancer outcomes. Higher scores were associated with decreased lung cancer risk only among male former smokers (HR, 0.84; 95% CI, 0.79–0.89) and female current smokers (HR, 0.89; 95% CI, 0.82–0.96). Higher scores were associated with 7% to 19% decreased breast cancer risk across smoking strata and 10% to 14% decreased colorectal cancer risk among male and female never and former smokers. Conclusions: Greater recommendations adherence was associated with reduced cancer risk. Impact: Findings emphasize the importance of considering combined contributions of multiple lifestyle factors for cancer prevention among older adults and the potential modifying role of smoking history.

2 June 2022 in Current Developments in Nutrition
Verified
Journal Article
Open access
PDF file
MSMarissa M Shams-White
Marissa M Shams-White
NBNigel T Brockton
Nigel T Brockton
PMPanagiota Mitrou
Panagiota Mitrou
LKLisa L Kahle
Lisa L Kahle
JRJill Reedy
Jill Reedy
The World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) published Cancer Prevention Recommendations in 2018 focused on modifiable lifestyle factors. To examine how adherence to WCRF/AICR Recommendations via the 2018 WCRF/AICR Score was associated with risk for all-cause, cancer, and CVD mortality outcomes among older US adults. Baseline and follow-up questionnaire data (N = 177,410) were used to calculate weight, physical activity, and diet components of the 2018 WCRF/AICR Score (0–7 total points). Adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated, stratified by sex and smoking status. There were 16,055 deaths during a mean 14.2 person-years. Each one-point Score increase was associated with a 9–26% reduced mortality risk for all outcomes, except for current male smokers’ cancer mortality risk. When the Score was categorized comparing highest (5–7 points) vs. lowest (0–2 points) Scores, associations with reduced all-cause mortality risk were strongest in former smokers (HRmales: 0.51, 95%CI: 0.43–0.61; HRfemales: 0.38, 95%CI: 0.31–0.46), followed by current smokers (HRmales: 0.55, 95%CI: 0.34–0.89; HRfemales: 0.44, 95%CI: 0.32–0.59) and never smokers (HRmales: 0.57, 95%CI: 0.47–0.70; HRfemales: 0.50, 95%CI: 0.41–0.60). An association with cancer mortality risk was also seen in former smokers (HRmales: 0.59, 95%CI: 0.43–0.81; HRfemales: 0.52, 95%CI: 0.37–0.73) and female current (HRfemales: 0.55, 95%CI:0.32–0.96) and never smokers (HRfemales: 0.57, 95%CI: 0.40–0.80); findings were not statistically significant in other strata. For CVD mortality, highest vs. lowest Scores were associated with a 49–73% risk reduction, except in male never and current smokers. In exploratory analysis, physical activity, body weight, alcohol, and plant-based foods were found to be predominant components in the Score. Greater 2018 WCRF/AICR Scores were associated with lower mortality risk among older adults. Future research can explore how smoking modifies these relationships, and further examine different populations and other cancer-relevant outcomes.

25 August 2017 in Oncology Letters
Verified
Journal Article
Open access
PDF file
NBNigel T Brockton
Nigel T Brockton
PLPawadee Lohavanichbutr
Pawadee Lohavanichbutr
EEEmeka K. Enwere
Emeka K. Enwere
MUMelissa P. Upton
Melissa P. Upton
EKElizabeth N. Kornaga
Elizabeth N. Kornaga
JDJoseph C. Dort
Joseph C. Dort
Oral squamous cell carcinoma (OSCC) is the most commonly diagnosed type of head and neck cancer, accounting for similar to 300,000 new cases worldwide annually. Carbonic anhydrase IX (CAIX) and Ki-67 have been associated with reduced disease-specific survival (DSS) in patients with OSCC. We previously proposed a combined CAIX and Ki-67 signature of 'functional hypoxia' and sought to replicate this association in a larger independent cohort of patients with OSCC at the Fred Hutchinson Cancer Research Center (FHCRC) in Seattle. The study population included patients with incident primary OSCC treated at the University of Washington Medical Center and the Harborview Medical Center in Seattle between December 2003 and February 2012. Archived tumor blocks were obtained with tissue samples from 189 patients, and triplicate 0.6 mm cores were assembled into tissue microarrays (TMAs). Fluorescence immunohistochemistry and AQUAnalysis (TM) were used to quantify the expression of tumoral CAIX (tCAIX) and stromal CAIX (sCAIX) and tumoral Ki-67 for each TMA core. Hazard ratios for DSS were calculated using Cox proportional hazards analysis. High tCAIX and sCAIX expression levels were associated with reduced DSS (aHR=1.003, 95% CI: 1.00-1.01 and aHR=1.010, 95% CI: 1.001-1.019, per AQUA score unit, respectively). Ki-67 expression was not associated with survival (aHR=1.01, 95% CI: 0.99-1.02) in the FHCRC cohort. DSS for patients with high sCAIX and low Ki-67 did not differ from that of other patient groups. Elevated tCAIX was associated with reduced DSS as a continuous and as a dichotomized (75%) variable. sCAIX was associated with DSS as a continuous variable but not when dichotomized (75%). However, the previously proposed 'functional hypoxia' signature was not replicated in the current FHCRC study. The failure to replicate our prior observation of poorer survival in patients with combined high sCAIX and low tumoral Ki-67 was likely due to the absence of an association between tumoral Ki-67 and DSS in this cohort. However, the association between DSS and tCAIX and sCAIX supports a role for CAIX in OSCC clinical outcomes.

13 March 2025 in ESMO Open
Verified
Journal Article
Open access
GMGeorgios Markozannes
Georgios Markozannes
Sofia CividiniSofia Cividini
Sofia Cividini
DAD. Aune
D. Aune
NBN. Becerra-Tomás
N. Becerra-Tomás
SKS. Kiss
S. Kiss
DCD.S.M. Chan
D.S.M. Chan
The impact of physical activity, sedentary behaviour, diet, adiposity, and body composition on health-related quality of life (HRQoL) and cancer-related fatigue among colorectal cancer survivors remains uncertain. PubMed, Embase, and CENTRAL were systematically searched until April 2023 for relevant randomised controlled trials (RCTs) and cohort studies. Random-effects meta-analyses or descriptive syntheses were conducted depending on the number of studies. The evidence was interpreted and graded by an independent World Cancer Research Fund Expert Committee and Expert Panel. We included 31 RCTs (18 exercise, 14 diet) and 30 cohort studies (8 physical activity, 3 sedentary behaviour, 13 diet, 9 adiposity and body composition). Meta-analyses were possible for exercise RCTs that showed non-significant effects but indicative of improved HRQoL (overall four trials for global HRQoL, physical and emotional well-being) and fatigue (five trials). These studies were rated at a high risk of bias (RoB), and evidence was graded as 'very low certainty of an effect'. Descriptive synthesis of interventions to improve diet quality suggested small improvements in global HRQoL and physical well-being, but with a high RoB rating leading to a 'low certainty' grading. Evidence from RCTs on probiotics and supplements and evidence from observational studies on sedentary behaviour, and various dietary and body composition factors was generally inconsistent and too scarce to draw conclusions. Exercise and diet quality interventions might improve HRQoL and fatigue outcomes in colorectal cancer survivors. The evidence overall was limited and should be strengthened by larger, well-designed RCTs across the cancer continuum.